Glucose dehydrogenase mutant with high pH tolerance and application thereof
By performing site-directed mutation of glucose dehydrogenase, a mutant with high pH tolerance is obtained, which solves the problem of poor activity of existing enzymes at different pH values, and achieves efficient catalytic reactions in a wide range, which is suitable for multi-field applications. .
Patent Information
- Application Number
- CN202411254902.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-09
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2044-09-09
AI Technical Summary
The existing glucose dehydrogenase has poor catalytic reaction efficiency and stability under environments with higher or lower pH values, which limits its application in biopharmaceuticals and other fields.
Four mutants were obtained, including G28V/A55N, G28V/A55M, V72L/L122M and L122V, enhancing their pH range of 5.0-12.0 Enzyme activity, a method for preparing mutants was designed and implemented.
The mutant significantly improves the enzyme activity under different pH conditions, especially in alkaline solutions, which is better than the original enzyme, improves the production efficiency of D-gluconic acid and NADH, and is suitable for the food industry and pharmaceutical industry.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
Technical Field
[0001] The invention relates to a glucose dehydrogenase mutant, in particular to a pH stress-resistant glucose dehydrogenase mutant and a preparation method thereof, and belongs to the field of protein engineering. Background Art
[0002] Glucose dehydrogenase (GDH) is a redox enzyme that is widely present in nature. GDH mainly catalyzes the oxidation reaction of glucose, converting glucose into gluconic acid and hydrogen ions. This process not only involves the oxidation of glucose, but is also accompanied by the transfer of electrons. The generated hydrogen ions can combine with the oxidized coenzyme NAD+ or NADP+ to generate the reduced coenzyme NADH or NADPH, forming a cofactor regeneration cycle. GDH is therefore used in drug development. For example, in the process of manufacturing chiral brain peptidase inhibitors, GDH is used as a coenzyme of imine reductase to construct the NAD(P)H circulation system. In addition, GDH is widely used in industries such as prodrug screening, biomarker detection, food safety, biosensors, and biofuel cells.
[0003] Although it has been applied in many fields, the activity of GDH as a biocatalyst is limited to a specific catalytic environment, including metal ions, cofactors and pH values. For example, in drug quality control and testing, the pH may vary greatly due to the properties of different solutions and samples. The existing GDH can tolerate a limited pH range and cannot maintain good catalytic reaction efficiency and stability at high or low pH, thus limiting the application of GDH in processes such as biopharmaceuticals. Summary of the invention
[0004] Purpose of the invention: The purpose of the present invention is to provide a glucose dehydrogenase mutant with high pH tolerance, and to provide a nucleic acid molecule encoding the mutant, a vector or recombinant cell or product containing the mutant, and a preparation method and application of the mutant.
[0005] Technical solution: In a first aspect, the present invention provides four glucose dehydrogenase mutants, wherein the amino acid sequence of the glucose dehydrogenase mutant is obtained by mutation of the sequence shown in SEQ ID NO.1, and the mutation is G28V / A55N or G28V / A55M or V72L / L122M or L122V.
[0006] Furthermore, the mutant has high pH tolerance, and the high pH tolerance includes that the mutant has higher enzyme activity at pH 5.0-12.0.
[0007] The present invention uses glucose dehydrogenase from Lysinibacillus sphaericus as the original enzyme, and its amino acid sequence is shown in SEQ ID No. 1, and its nucleotide sequence is shown in SEQ ID No. 2. The present invention obtains the glucose dehydrogenase mutant by site-directed mutagenesis. The present invention uses standard single letters and standard substitution notation of amino acids: G28V means that glycine (G) at the 28th position of the N-terminus is replaced by valine (V); G28V / A55N means that glycine (G) at the 28th position of the N-terminus is replaced by valine (V), and alanine (A) at the 55th position of the N-terminus is replaced by asparagine (N).
[0008] In a second aspect, the present invention provides a nucleic acid molecule encoding the glucose dehydrogenase mutant described in the first aspect. The nucleotide sequence of the nucleic acid molecule is obtained by base mutation of the sequence shown in SEQ ID NO.2.
[0009] In a third aspect, the present invention provides a vector comprising the nucleotide sequence described in the second aspect. The vector includes a cloning vector or an expression vector. The vector may be a plasmid or a virus.
[0010] In a fourth aspect, the present invention provides a recombinant cell, wherein the recombinant cell comprises the vector described in the third aspect.
[0011] In a fifth aspect, the present invention provides a method for preparing the glucose dehydrogenase mutant described in the first aspect, comprising the following steps: (1) designing point mutation primers, using a plasmid containing the SEQ ID NO.2 sequence as a template, performing a PCR reaction, and then performing a digestion reaction and a recombination reaction to obtain an expression vector carrying a mutant gene; (2) transferring the expression vector into a host bacterium for fermentation expression; and (3) collecting the host bacterium, disrupting the cells, and centrifuging to obtain the supernatant to obtain the glucose dehydrogenase mutant.
[0012] In a sixth aspect, the present invention provides a product, which comprises the glucose dehydrogenase mutant according to claim 1 or the nucleic acid molecule according to any one of claims 2 to 3 or the vector according to claim 4 or the recombinant cell according to claim 6.
[0013] In a seventh aspect, the present invention provides a use of the product described in the sixth aspect in catalyzing D-glucose and NAD+ to generate D-gluconic acid and NADH.
[0014] Beneficial effects: Compared with the prior art, the present invention has the following significant advantages: 1. The four glucose dehydrogenase mutants provided by the present invention have high pH tolerance, the enzyme activity of the mutants G28V / A55N, G28V / A55M and V72L / L122M in alkaline solution is better than that of the original enzyme, and the enzyme activity of G28V / A55M and L122V in acidic solution is better than that of the original enzyme; 2. The glucose dehydrogenase mutants provided by the present invention can improve the production efficiency and product quality of D-gluconic acid and NADH, can be applied to many fields such as the food industry and the pharmaceutical industry, and are conducive to the development of new technologies and methods. BRIEF DESCRIPTION OF THE DRAWINGS
[0015] Figure 1 A schematic diagram of the structure of glucose dehydrogenase used in the present invention (with amino acid positions 28 and 55 highlighted);
[0016] Figure 2 A schematic diagram of the structure of glucose dehydrogenase used in the present invention (with amino acid positions 72 and 122 highlighted);
[0017] Figure 3 Schematic diagram of the enzyme activity of glucose dehydrogenase mutants in different alkaline solutions;
[0018] Figure 4 Schematic diagram of the enzyme activity of glucose dehydrogenase mutants in different acidic solutions. DETAILED DESCRIPTION
[0019] The technical solution of the present invention is further described below in conjunction with the accompanying drawings.
[0020] The culture medium and components used in the embodiments of the present invention are as follows:
[0021] LB medium: tryptone 10 g / L, yeast extract 5 g / L, sodium chloride 10 g / L;
[0022] LB solid medium: tryptone 10 g / L, yeast extract 5 g / L, sodium chloride 10 g / L, agar 15 g / L;
[0023] TB medium: yeast extract 12 g / L, tryptone 12 g / L, glycerol 4 ml / L, dipotassium hydrogen phosphate 12.5 g / L, potassium dihydrogen phosphate 2.3 g / L.
[0024] Example 1 Glucose dehydrogenase mutant G28V / A55N
[0025] In this example, the glycine at position 28 of the original enzyme sequence of glucose dehydrogenase shown in SEQ ID No. 1 is mutated to valine, and the alanine at position 55 is mutated to asparagine. The nucleic acid sequence of the original enzyme of glucose dehydrogenase is shown in SEQ ID No. 2, and the structure is shown in Figure 1 The preparation method of the mutant G28V / A55N is as follows: 1. constructing a recombinant plasmid; 2. expressing the enzyme mutant and preparing a crude enzyme solution. The specific method is as follows:
[0026] 1. Construction of recombinant plasmid
[0027] The original GDH enzyme gene shown in SEQ ID No. 2 was synthesized by GENEWISE (Suzhou) and inserted between the NdeI and XhoI restriction sites of the pET22b plasmid. The first round of point mutation PCR was performed using this plasmid as a template, the primers are shown in Table 1, and the reaction system and reaction procedure are shown in Tables 2 and 3.
[0028] Table 1 Primers for the first round of point mutation PCR of mutant G28V / A55N
[0029] Point mutation primer name Sequence (5'-3') G28V-F GCGCTTTGTGGAAGAAAAAGCGAAAGTTATCG G28V-R TTTCTTCACAAAGCGCAGCGCCATCGCTTTG
[0030] Table 2 Point mutation PCR system
[0031] Composition volume 2×ProofastMaxMasterMix 12.5μL 10pmol / μLForwardPrimer 1μL 10pmol / μLReversePrimer 1μL DNA template <50ng <![CDATA[ddH2O]]> up to 25 μL
[0032] Table 3 Point mutation PCR reaction procedure
[0033]
[0034]
[0035] After PCR, digestion reaction was performed as described in Table 4.
[0036] Table 4 Digestion reaction system
[0037] Composition content Point mutation PCR reaction products 25μL DpI 1μL
[0038] The above reaction system was placed in a constant temperature reaction at 37°C for 2 hours.
[0039] After the digestion reaction was completed, the recombination reaction was performed as described in Table 5.
[0040] Table 5 Recombination reaction system
[0041] Composition content DpnI digestion products 4μL 5×UFOBuffer 4μL UvsXase 2μL <![CDATA[ddH2O]]> up to 20 μL
[0042] The reaction system was placed at 37°C for 1 hour. The resulting product was a recombinant plasmid containing the designed point mutation G28V, which was sequenced by GENEWIZ (Suzhou) Co., Ltd. to confirm the mutation result.
[0043] The second round of point mutation PCR was performed using the above recombinant plasmid with the point mutation G28V as a template. The primers used are shown in Table 6.
[0044] Table 6 Second round of point mutation PCR primers for mutant G28V / A55N
[0045] Point mutation primer name Sequence (5'-3') A55N-F GTGAAAAAAAACGGCGGCGATGCGATTGCGGTG A55N-R GCCGCCGTTTTTTTTCACGCCTTCCACCACCGCG
[0046] The reaction system and reaction procedure of PCR are consistent with those in Tables 2 and 3 above. After the PCR is completed, digestion reaction and recombination reaction are carried out, and the reaction procedures and conditions are consistent with those in Tables 4 and 5 above. After the recombination reaction is completed, the obtained product is a recombinant plasmid containing the designed point mutation G28V / A55N, and the mutation result is confirmed by sequencing by GENEWIZ (Suzhou) Company.
[0047] 2. Expression of enzyme mutants and preparation of crude enzyme solution
[0048] The plasmid with the mutant enzyme gene was transformed into E.coli BL21 (DE3) bacteria and screened with LB solid medium containing 100μg / mL ampicillin. The positive transformants were picked to LB liquid medium containing 100μg / mL ampicillin for overnight culture as the seed liquid for fermentation. With a 5% inoculation amount, the seed liquid was inoculated into a 250ml conical flask containing 30ml TB medium and cultured at 37℃ and 200rpm for 6-8h. Add 24μL 0.5M IPTG to the fermentation liquid, adjust the culture temperature to 24℃, and continue to culture for 18h. After the fermentation is completed, all the fermentation liquid was collected and centrifuged at low temperature to remove the supernatant. After resuspending the cells with 15ml of the corresponding buffer, ultrasonically crush the cells for 3min until the bacterial suspension is slightly clear. Centrifuge the cell crushing liquid at 4000g for 10min, and take the supernatant as the crude enzyme liquid containing the mutant.
[0049] Example 2 Glucose dehydrogenase mutant G28V / A55M
[0050] In this example, the amino acid glycine at position 28 of the original glucose dehydrogenase sequence shown in SEQ ID No. 1 is mutated to valine, and the amino acid alanine at position 55 is mutated to methionine. The nucleic acid sequence of the original glucose dehydrogenase is shown in SEQ ID No. 2, and the structure is shown in Figure 1 The second round of point mutation primers are shown in Table 7, and the rest of the preparation method is the same as Example 1.
[0051] Table 7 Second round of point mutation PCR primers for mutant G28V / A55M
[0052] Point mutation primer name Sequence (5'-3') A55M-F GTGAAAAAAATGGGCGGCGATGCGATTGCGGTG A55M-R GCCGCCCATTTTTTTCACGCCTTCCACCACCGCG
[0053] Example 3 Glucose dehydrogenase mutant V72L / L122M
[0054] In this example, the amino acid valine at position 72 of the original glucose dehydrogenase sequence shown in SEQ ID No. 1 is mutated to leucine, and the amino acid leucine at position 122 is mutated to methionine. The nucleic acid sequence of the original glucose dehydrogenase is shown in SEQ ID No. 2, and the structure is shown in Figure 2 The first and second round point mutation primers are shown in Tables 8 and 9, and the rest of the preparation method is the same as Example 1.
[0055] Table 8 Primers for the first round of point mutation PCR of mutant V72L / L122M
[0056] Point mutation primer name Sequence (5'-3') V72L-F GAAGATCTGATTAACCTGGTGCAGACCGCG V72L-R GTTAATCAGATCTTCTTCCACGGTCACATC
[0057] Table 9 Second round of point mutation PCR primers for mutant V72L / L122M
[0058] Point mutation primer name Sequence (5'-3') L122M-F GCGTTTATGGGCAGCCGCGAAGCGATTAAAT L122M-R GCTGCCCATAAACGCGCCGGTCAGGTTGGTG
[0059] Example 4 Glucose dehydrogenase mutant L122V
[0060] In this example, the amino acid leucine at position 122 of the original glucose dehydrogenase sequence shown in SEQ ID No. 1 is mutated to valine. The nucleic acid sequence of the original glucose dehydrogenase is shown in SEQ ID No. 2, and the structure is shown in Figure 2 In this example, only one point mutation was performed, the primers are shown in Table 10, and the rest of the preparation method is the same as in Example 1.
[0061] Table 10 PCR primers for mutant L122M point mutation
[0062]
[0063]
[0064] Example 5 Determination of the enzyme activity of glucose dehydrogenase in different alkaline solutions
[0065] The method in Example 1 was used to express the original glucose dehydrogenase and prepare the crude enzyme solution.
[0066] Based on the principle that glucose dehydrogenase catalyzes glucose and NAD+ to synthesize gluconic acid and NADH, and the characteristic that NADH has specific absorption at 340nm, the enzyme activities of the glucose dehydrogenase mutants and the original glucose dehydrogenase in Examples 1-4 were measured in different alkaline solutions. Enzyme activity definition: 1 nmol of NADH produced per minute per 1 mL of sample is defined as one enzyme activity unit (U). The specific determination method is as follows:
[0067] Prepare different alkaline solutions: (1) 100 mM Tris-HCl buffer, pH 8.0: Take 12.11 g of Tris, add 1 L of deionized water, and adjust the pH to 8.0 with 38% concentrated hydrochloric acid; (2) 100 mM Tris-HCl buffer, pH 9.0: Take Tris 12.11g, add 1L of deionized water, and adjust the pH to 9.0 with 38% concentrated hydrochloric acid; (3) 100mM, pH 10.0 glycine-sodium hydroxide buffer: take 7.51g of glycine, add 1L of deionized water, and adjust the pH to 10.0 with sodium hydroxide; (4) 100mM, pH 11.0 glycine-sodium hydroxide buffer: take 7.51g of glycine, add 1L of deionized water, and adjust the pH to 11.0 with sodium hydroxide; (5) 100mM, pH 12.0 glycine-sodium hydroxide buffer: take 7.51g of glycine, add 1L of deionized water, and adjust the pH to 12.0 with sodium hydroxide.
[0068] Preheat the microplate reader for 30 minutes, use the endpoint method, adjust the wavelength to 340nm, and adjust to zero with deionized water. Add 100μL of 20mM glucose solution, 100μL of 20mM NAD solution, and 50μL of crude enzyme solution to the 96-well microplate, respectively, and place in a 30°C water bath. Immediately start the reaction, and measure the absorbance of the reaction solution at 340nm at the beginning of the reaction and 10 minutes of reaction, respectively, recorded as A0 and A1. The difference between the two measured values represents the amount of NADH generated by the GDH enzymatic reaction, recorded as ΔA. GDH enzyme activity is defined as one enzyme activity unit (U) produced per 1mL sample per minute at 1nmol of NADH. Calculate the enzyme activity according to the following formula:
[0069] GDH enzyme activity (U / L) = ΔA ÷ (ε×d) × 10 9 ×V 反应 ÷V 样品 ÷T
[0070] Where, ε is the molar extinction coefficient of NADH, 6220 (L / mol / cm); d is the light path of the ELISA plate, 0.6 cm; 10 9 is the unit conversion factor; V 反应 is the total reaction volume, 0.3 ml; V 样品 is the added sample volume, 0.05 ml; T is the reaction time, 10 min.
[0071] The reaction results are as follows Figure 3 As shown in the figure, at pH 8.0, 10.0, 11.0, and 12.0, the enzyme activities of mutants G28V / A55N, G28V / A55M, and V72L / L122M were significantly improved compared with the original enzyme. When the pH was 8.0, the enzyme activity of mutant G28V / A55N was increased by 40.0% compared with the original enzyme, reaching 5.0×10 5U / mL; when the pH was 10.0 and 11.0, the enzyme activity of mutant G28V / A55M increased by 108.0% and 192.4% respectively compared with the original enzyme, reaching 4.4×10 5 U / mL, 4.9×10 5 U / mL; when the pH was 12.0, the activity of mutant V72L / L122M was 2.86 times higher than that of the original enzyme, reaching 2.6×10 5 The above results show that the mutants G28V / A55N, G28V / A55M and V72L / L122M provided in the present invention maintain good enzyme activity under alkaline conditions compared with the original enzyme, and have the ability to be used in alkaline reaction conditions.
[0072] Example 6 Determination of the enzyme activity of glucose dehydrogenase in different acidic solutions
[0073] The enzyme activity determination method of this example is the same as that of Example 5 except that an acidic solution is used.
[0074] Prepare different acidic solutions: (1) 100 mM, pH 7.0 phosphate buffer: take 8.59 g of disodium hydrogen phosphate and 4.73 g of sodium dihydrogen phosphate, add deionized water to make up to 1 L; (2) 100 mM, pH 6.0 phosphate buffer: take 1.65 g of disodium hydrogen phosphate and 10.60 g of sodium dihydrogen phosphate, add deionized water to make up to 1 L; (3) 100 mM, pH 5.0 acetate buffer: take 1.743 mL of glacial acetic acid and 5.72 g of sodium acetate, add deionized water to make up to 1 L.
[0075] The reaction results are as follows Figure 4 As shown in the figure, at pH 7.0, 6.0, and 5.0, the enzyme activities of mutants G28V / A55M and L122V were better than those of the original enzyme. When the pH was 7.0, the enzyme activity of mutant G28V / A55M increased by 178.1% compared with the original enzyme, reaching 5.1×10 5 U / mL; when the pH was 6.0 and 5.0, the enzyme activity of mutant L122V was increased by 3.2 times and 9.5 times compared with the original enzyme, reaching 1.9×10 5 U / mL, 1.3×10 5 The above results show that the mutants G28V / A55M and L122V provided in the present invention have improved enzyme activity under acidic conditions compared with the original enzymes, and have application potential in acidic conditions.
Claims
1. A glucose dehydrogenase mutant, characterized in that: The amino acid sequence of the glucose dehydrogenase mutant is obtained by mutation of the sequence shown in SEQ ID NO.1, and the mutation is G28V / A55N or G28V / A55M or V72L / L122M or L122V.
2. A nucleic acid molecule, characterized in that The nucleic acid molecule encodes the glucose dehydrogenase mutant according to claim 1.
3. The nucleic acid molecule according to claim 2, characterized in that The nucleotide sequence of the nucleic acid molecule is obtained by base mutation of the sequence shown in SEQ ID NO.
2.
4. A carrier, characterized in that Comprising the nucleotide sequence of claim 3.
5. A recombinant cell, characterized in that The recombinant cell comprises the vector of claim 4.
6. A method for preparing the glucose dehydrogenase mutant according to claim 1, characterized in that: The following steps are involved: (1) Designing point mutation primers, using a plasmid containing the sequence of SEQ ID NO.2 as a template, performing a PCR reaction, and then performing a digestion reaction and a recombination reaction to obtain an expression vector carrying a mutant gene; (2) Transferring the expression vector into a host bacterium for fermentation expression; (3) Collecting the host bacterium, disrupting the cells, and centrifuging to obtain the supernatant to obtain a glucose dehydrogenase mutant.
7. A product, characterized in that The product comprises the glucose dehydrogenase mutant according to claim 1 or the nucleic acid molecule according to any one of claims 2 to 3 or the vector according to claim 4 or the recombinant cell according to claim 6.
8. Use of the product according to claim 8 in catalyzing D-glucose and NAD+ to generate D-gluconic acid and NADH.
9. The glucose dehydrogenase mutant according to claim 1, characterized in that The mutant has high pH tolerance.
10. The glucose dehydrogenase mutant according to claim 9, characterized in that The high pH tolerance ability includes that the mutant has higher enzyme activity at pH 5.0-12.0.
Citation Information
Patent Citations
Alkali-resistant glucose dehydrogenase genes, polypeptide encoded by same and method for preparing polypeptide
CN101717777A
Endoglucanase mutant with improved pH tolerance and preparation method thereof
CN118910016A
Heat-resistant glucose dehydrogenase mutant and preparation method thereof
CN119193516A
Glutamate dehydrogenase mutants and their application in preparation of l-phosphinothricin
US20200102546A1
